Corporate Governance at Merck
|
Case Code: CGOX004 Case Length: 12 Pages Period: 2003 Pub Date: 2003 Teaching Note: Not Available |
Price: Rs.300 Organization: Merck Industry: Pharmaceutical Countries: Germany Themes: - |
Abstract Case Intro 1 Excerpts
Abstract
Merck is one of the leaders in the global pharmaceutical industry. The company is well known for its high cholesterol, hypertension, and heart-failure drugs. The company's famous drugs include Cozaar and Hyzaar (blood pressure), Zetia and Zocor (cholesterol), Vioxx (pain killer), Propecia (male pattern baldness treatment) and Singulair (asthma). Merck has put in place various measures to ensure high standards of corporate governance. A system of committees helps the Board in discharging its responsibilities. This case deals with Merck's corporate governance practices.
Issues
The case is structured to achieve the following teaching objectives:
- This case deals with Merck''s corporate governance practices
Contents
-
Introduction
Background Note
Overview of Corporate Governance
Board Committees and their Responsibilities
Board and Board Committee Meetings
Independence of Directors
Board's Role in Strategic Planning
Compensation of Directors
Election of Board Members
Exhibits
Keywords
Merck; Corporate governance; Governance; Pharmaceutical industry; Board structures; Board committees; Director compensation; Board members; Vioxx; Cozaar; Audit committee; Compensation and benefits committee; Executive committee; Finance committee; Social responsibility
Buy this case study (Please select any one of the payment options)
| Price: Rs.300 |
Price: Rs.300 | PayPal (7 USD) |
